Vimarsana
Biggest News Aggregation in the World

Page 23 - Chen Wei News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chen Wei. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chen Wei Today - Breaking & Trending Today

Overseas Chinese confident about China's complete reunification - Vimarsana News

Overseas Chinese confident about China's complete reunification

China has recently released a white paper on the Taiwan question and China's reunification in the new era, which resonated strongly among overseas Chinese.

Canada Sent Nipah Virus to Wuhan; Lab Conducts 'Most Dangerous Research' on Nipah, Scientist Testifies to US Senate - Vimarsana News

Canada Sent Nipah Virus to Wuhan; Lab Conducts 'Most Dangerous Research' on Nipah, Scientist Testifies to US Senate

An American scientist recently testified at a U.S. Senate hearing that his research provides evidence that the Wuhan ...

China economy: Love affair with housing hangs by a thread - Vimarsana News

China economy: Love affair with housing hangs by a thread

Beijing is looking to spend its way out of a post-pandemic economic downturn, but for the first time in decades the country’s obsession with housing is showing signs of waning.

Source: afr.com
Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration - Vimarsana News

Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration

BEIJING, June 23, 2022 /PRNewswire/ --Ocumension Therapeutics 1477.HKannounced that the New Drug Application (NDA) for the core product in its pipeline, OT-401 (Sterile non-bioerodible intravitreal implant, Product name: YUTIO), was officially approved by the National Pharmaceutical Administration (NMPA) for the treatment of chronic non-infectious uveitis involving the posterior segment of the eye (chronic NIU-PS). This is the first new drug in Ocumension's pipeline to be approved for marketing and is currently the potential best-in-class therapy for the treatment of this indication in Chi...

Origins of Coronavirus Controversy - Vimarsana News

Origins of Coronavirus Controversy

Growing indications of viral enhancement research gone awry is still a possible origin of coronavirus and cause of the pandemic.